Sahamongkol buys Thai rights to 'Dear You' after $275M China hit; releases August 6

Sahamongkol Film Co is bringing the Chinese family drama Dear You to Thai theaters after the movie proved itself in mainland China. Deadline reports the company acquired Thai distribution rights for Dear You, produced by China’s Damai Entertainment, and is planning a theatrical release in Thailand on August 6.

The headline number is the point: Dear You grossed $275M in mainland China, a performance that Deadline describes as massively outperforming expectations for a relatively small drama film without major stars. In other words, this was not a “big celebrity launches the ship” story. It was a quiet bet on audience pull from the genre itself, and then the money backed it.

For executives and dealmakers, this is the blueprint that is getting copied across Asia right now. The Thai market is not isolated, and distribution rights are increasingly won or priced based on evidence from the largest nearby testing ground: mainland China. When a drama films outperforms expectations on scale, local distributors can justify a higher level of confidence around attendance and longevity, even if the title does not look like an obvious blockbuster on paper.

The “without major stars” detail matters more than it sounds. Star-driven films can convert marketing spend directly into turnout, but they also create bigger downside risk if the casting does not travel. Family dramas often behave differently. They can build repeat viewership and word-of-mouth, especially when the story offers something cross-cultural audiences can immediately recognize: family stakes, relationships, and emotional payoff. The fact that Dear You delivered $275M gives Sahamongkol a measurable case study that this kind of content can travel, at least from mainland China to Thailand.

There is also a timing and rollout incentive hiding in plain sight. A confirmed Thai theatrical release date on August 6 creates a schedule anchor for exhibitors, advertisers, and marketing partners. Distributors who lock release windows early typically gain better control of screens and promotional slots, which can translate into higher per-week attendance. That matters for dramas in particular, because their economic model often depends on sustaining ticket sales rather than peaking in a single weekend.

From an industry perspective, cross-border distribution deals like this also help studios and producers think beyond their domestic box office. Damai Entertainment, the producer, benefits when a mainland hit becomes an export title with defined theatrical timelines. For distributors like Sahamongkol, acquiring rights is a form of risk management: you are buying the likelihood that audiences will show up, based on verified box office performance. The $275M figure is not just publicity. It is underwriting.

Now zoom out to the second-order implications for other executives sitting in similar roles. When a distributor can point to a mainland hit that “should not have” worked because it lacked major stars, it changes internal approval dynamics. Budget committees and investment teams often want reasons. Dear You supplies a reason that is both simple and hard to argue with: it earned $275M, and it did so as a relatively small drama.

That can shift how future slates are evaluated across territories. If Sahamongkol’s Dear You rollout performs in Thailand, the next rights conversations may tilt toward mid-budget, story-led projects that look underpowered by traditional blockbuster metrics. Boardrooms do not need metaphors. They just need results, and Deadline is telling you the key result already happened.

In the end, the strategic stakes are clear. Sahamongkol is using mainland proof to reduce guesswork, placing a Chinese audience-tested family drama into Thailand with a specific launch date on August 6. If the Thai release catches on the way the China run did, this single title can justify more cross-border rights hunting. If it misses, the market will learn the hard way that $275M is not automatically portable. Either way, Dear You is a live test of whether story-led drama can keep winning when stars are not doing the heavy lifting.